Evogene Ltd.

EVGN

IL0011050551

Biotechnology & Medical Research

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 10:13:55 2024-07-17 am EDT			5-day change	1st Jan Change
230.2 ^ILa	-2.17%		+0.39%	-23.22%

03:26pm	ICL, Lavie Bio Say AI Collaboration Has Helped in Search for Crop Bio-Stimulants	MT
Jun. 20	Nir Arbel Steps Down as Chief Product Officer of Evogene Ltd	CI

Evogene Ltd.(NasdaqGM:EVGN) added to NASDAQ Composite Index

January 03, 2017 at 12:00 am EST

Evogene Ltd. has been added to NASDAQ Composite Index.

Latest news about Evogene Ltd.

ICL, Lavie Bio Say AI Collaboration Has Helped in Search for Crop Bio-Stimulants	09:26am	MT
Nir Arbel Steps Down as Chief Product Officer of Evogene Ltd	Jun. 20	CI
Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M	May. 23	MT
Evogene Ltd. Provides Revenue Guidance for the Year 2024	May. 23	CI
Transcript : Evogene Ltd., Q1 2024 Earnings Call, May 23, 2024	May. 23
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 23	CI
Evogene Ltd. and The Kitchen FoodTech Hub Establishes Finally Foods Ltd	Apr. 02	CI
Evogene Receives Minimum Bid Price Non-Compliance Notice From Nasdaq	Mar. 20	MT
Transcript : Evogene Ltd., Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
Evogene Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Evogene Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
Evogene Unit, Corteva Agriscience Identify New Potential Class of Herbicidal Molecules	Mar. 06	MT
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides	Mar. 06	CI
Casterra Announces New Agreements with Subsidiary of Evogen Ltd., to Meet Growing Demand for Its Elite Castor Seed Varieties	Mar. 05	CI
Evogene Files $200 Million Mixed Shelf	Mar. 01	MT
Evogene Ltd. and Verb Biotics LLC Enters into Collaboration Agreement	Feb. 06	CI
Casterra Ag Ltd., a subsidiary of Evogene Ltd Announces Executive Changes, Effective January 1, 2024	Dec. 19	CI
Transcript : Evogene Ltd., Q3 2023 Earnings Call, Nov 15, 2023	Nov. 15
Earnings Flash (EVGN) EVOGENE Posts Q3 Revenue $3.8M	Nov. 15	MT
Evogene Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
Colors Farm Ltd, Evogene Ltd. and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology	23-10-31	CI
Alliance Global Starts Evogene at Buy With $1.85 Price Target	23-10-02	MT
Lake Street Adjusts Evogene's Price Target to $3 From $2, Keeps Buy Rating	23-08-18	MT
Transcript : Evogene Ltd., Q2 2023 Earnings Call, Aug 17, 2023	23-08-17
Earnings Flash (EVGN) EVOGENE Posts Q2 Revenue $654,000	23-08-17	MT

Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Sector

Biotechnology & Medical Research

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
EVOGENE LTD.	-23.22%	32.94M
MODERNA, INC.	+24.97%	47.96B
IQVIA HOLDINGS INC.	+1.89%	42.45B
LONZA GROUP AG	+44.47%	41.47B
ALNYLAM PHARMACEUTICALS, INC.	+27.63%	31.6B
ICON PUBLIC LIMITED COMPANY	+21.43%	28.63B
CELLTRION, INC.	-6.35%	28.03B
UNITED THERAPEUTICS CORPORATION	+52.27%	14.56B
MEDPACE HOLDINGS, INC.	+47.20%	14.14B
BIO-TECHNE CORPORATION	+4.12%	12.58B

Other Biotechnology & Medical Research

Evogene Ltd.

Equities

EVGN

IL0011050551

Biotechnology & Medical Research

Evogene Ltd.(NasdaqGM:EVGN) added to NASDAQ Composite Index

Latest news about Evogene Ltd.

Chart Evogene Ltd.

Company Profile

Income Statement Evolution

Quarterly revenue - Rate of surprise

Sector Other Biotechnology & Medical Research